childhood cancer survivors. Cancer, Epidemiology, Biomarkers and Prevention, 23 (9), 1913–1919. doi:10.1158/1055-9965.EPI-14-0292 Ruggiero, A., Ferrara, P., Attinà, G., Rizzo, D. e Riccardi, R. (2017). Renal toxicity and chemotherapy in children with cancer. British Journal of Clinical Pharmacology, 31. doi:10.1111/bcp.13388 Running, A. e Turnbeaugh, E. (2011). Oncology pain and complementary therapy. Clinical Journal of Oncology Nursing, 15 (4), 374-379. doi:10.1188/11.CJON.374-379 Saborio, P., Tipton, G. A. e Chan, J. C. (2000). Diabetes insipidus. Pediatrics in Review, 21 (4), 122–129. doi:10.1542/pir.21-4-122 Salmasi, G., Li, M., Sivabalasundaram, V., Panzarella, T., Tsang, R., Kukreti, V., . . . Kuruvilla, J. (2015). Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab. Leukemia and Lymphoma, 56 (6), 1659–1664. doi:10.3109/10428194.2014.963075 Schempp, A., Lee, J., Kearney, S., Mulrooney, D. A. e Smith, A. R. (2016). Iron overload in survivors of childhood cancer. Journal of Pediatric Hematology Oncology, 38 (1), 27-31. doi:10.1097/ MPH.0000000000000444 Schmid, K. E., Kornek, G. V., Scheithauer, W. e Binder, S. (2006). Update on ocular complications of systemic cancer chemotherapy. Survey of Ophthalmology, 51 (1), 19–40. doi:10.1016/j.survophthal.2005.11.001 Science, M., Robinson, P. D., MacDonald, T., Rassekh, S. R., Dupuis, L. L. e Sung, L. (2014). Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients . Edmonton, AB, Canada: C17 Council. Extraído de: www. c17.ca/files/5213/9343/4155/C17_ Antifungal_Guideline_Feb_26_2014_Final_Full.pdf Secola, R., Marachelian, A., Cohn, S. L., Toy, B., Neville, K., Granger, M., . . . Martin, G. (2017). The role of nursing professionals in the management of patients with high-risk neuroblastoma receiving dinutuximab therapy. Journal of Pediatric Oncology Nursing, 34 (3), 160-172. doi:10.1177/1043454216680595 Serkies, K., Badzio, A. e Jassem, J. (2006). Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapy. Acta Oncologica, 45 (6) , 695–701. doi:10.1080/02841860600833160 Sheu, J., Hawryluk, E. B., Guo, D., London, W. B. e Huang, J. T. (2015). Voriconazole phototoxicity in children: A retrospective review. Journal of the American Academy of Dermatology, 72 (2), 314–320. doi:10.1016/j.jaad.2014.10.023 Siddall, E., Khatri, M. e Radhakrishnan, J. (2017). Capillary leak syndrome: Etiologies, pathophysiology, and management. Kidney International, 92 (1), 37-46. doi:10.1016/j.kint.20116.11.029 Silva, C. A. G. e Motta, M. E. F. A. (2013). The use of abdominal muscle training, breathing exercises and abdominal massage to treat paediatric chronic functional constipation. Colorectal Disease, 15 (5), e250–e255. doi:10.1111/codi.12160 Skeens, M. A., McArthur, J., Cheifetz, I. M., Duncan, C., Randolph, A. G., Stanek, J., . . . HSCT Subgroup of the Pediatric Acute Lung Injury & Sepsis Investigators (PALISI). (2016). High variability in the reported management of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 22 (10), 1823-1828. doi:10.1016/j.bbmt.2016.07.011 Skinner, R. (2017). Late renal toxicity of treatment for childhood malignancy: Risk factors, long-term outcomes, and surveillance. Pediatric Nephrology . doi:10.1007/s00467-017-3662-z Sonis, S. T. (2004). The pathobiology of mucositis. Nature Reviews Cancer, 4 (4), 277–284. doi:10.1038/nrc1318 Sonis, S. T. (2011). Oral mucositis. Anticancer Drugs, 22 (7), 607–612. doi:10.1097/CAD.0b013e3283462086 Sonis, S. T., Elting, L. S., Keefe, D., Peterson, D. E., Schubert, M., Hauer-Jensen, M., . . . Rubenstein, E. B. (2004). Perspectives on cancer therapy-induced mucosal injury. Cancer, 100 (59), 1995-2025. doi:10.1002/cncr.20162
Pessi, M. A., Zilembo, N., Haspinger, E. R., Molino, L., DiCosimo, S., Garassino, M. e Ripamonti, C. I. (2014). Targeted therapy-induced diarrhea: A review of the literature. Critical Reviews in Oncology/Hematology, 90 (2), 165-179. doi:10.1016/j. critrevonc.2013.11.008 Pfizer, Inc. (2011). Neumega®. Filadélfia, PA: Pfizer, Inc. Extraído de: https://www.pfizer.com/files/products/uspi_neumega.pdf Phillips, R. S., Friend, A. J., Gibson, F., Houghton, E., Gopaul, S., Craig, J. V. e Pizer, B. (2016). Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood. Cochrane Database of Systematic Reviews, 2016, CD007786. doi:10.1002/14651858.CD007786.pub3 Pillai, A. K., Sharma, K. K., Gupta, Y. K. e Bakhshi, S. (2011). Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy. Pediatric Blood and Cancer, 56 (2), 234-238. doi:10.1002/pbc.22778 Platteborze, P. L. e Wilhelms, K. W. (2015). Request for uric acid analysis on an iced specimen. Clinical Chemistry, 61 (9), 1212–1213. doi:10.1373/clinchem.2015.238808 Porta, C., Cosmai, L., Gallieni, M., Pedrazzoli, P. e Malberti, F. (2015). Renal effects of targeted anticancer therapies. Nature Reviews Nephrology, 11 (6), 354–370. doi:10.1038/nrneph.2015.15 Postow, M. A. (2015). Managing immune checkpoint-blocking antibody side effects. American Society of Clinical Oncology Education Book, 2015, 76–83. doi:10.14694/EdBook_AM.2015.35.76 Quimby, E. L. (2007). The use of herbal therapies in pediatric oncology patients: Treating symptoms of cancer and side effects of standard therapies. Journal of Pediatric Oncology Nursing, 24 (1), 35-40. doi:10.1177/1043454206296027 Quirion, E. (2009). Filgrastim and pegfilgrastim use in patients with neutropenia. Clinical Journal of Oncology Nursing, 13 (3), 324–328. doi:10.1188/09.CJON.324-328 Reitman, A. J., Coates, T. D. e Freyer, D. R. (2015). Early cardiac iron overload in a child on treatment of acute lymphocytic leukemia. Pediatrics, 136 (3), e697-700. doi:10.1542/peds.2014-3770 Reyes-Habito, C. M. e Roh, E. K. (2014a). Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: Part I. Conventional chemotherapeutic drugs. Journal of the American Academy of Dermatology, 71 (2), 203. doi:10.1016/j.jaad.2014.04.014 Reyes-Habito, C. M. e Roh, E. K. (2014b). Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: Parte II. Targeted therapy. Journal of the American Academy of Dermatology, 71 (2), 217. doi:10.1016/j.jaad.2014.04.013 Riachy, E., Krauel, L., Rich, B. S., McEvoy, M. P., Honeyman, J. N., Boulad, F., . . . La Quaglia, M. P. (2014). Risk factors and predictors of severity score and complications of pediatric hemorrhagic cystitis. Journal of Urology, 191 (1), 186–192. doi:10.1016/j.juro.2013.08.007 Rodrigues, A., Wong, C., Mattiussi, A., Alexander, S., Lau, E. e Dupuis L. L. (2013). Methylnaltrexone for opioid-induced constipation in pediatric oncology patients . Pediatric Blood and Cancer, 60 (10), 1667-1670. doi:10.1002/pbc.246515 Romao, R. L. e Lorenzo, A. J. (2017). Fertility preservation options for children and adolescents with cancer. Canadian Urological Association Journal, 11 (1–2 suppl), S97–S102. doi:10.5489/cuaj.4410 Rosman, I. S., Lloyd, B. M., Hayashi, R. J. e Bayliss, S. J. (2008). Cutaneous effects of thiotepa in pediatric patients receiving high- dose chemotherapy with autologous stem cell transplantation. Journal of the American Academy of Dermatology, 58 (4), 575–578. doi:10.1016/j.jaad.2007.12.037 Roubinian, N. H. e Murphy, E. L. (2015). Transfusion-associated circulatory overload (TACO): Prevention, management, and patient outcomes. International Journal of Clinical Transfusion Medicine, 3, 17–28. doi:10.2147/IJCTM.S77343 Ruccione, K. S., Wood, J. C., Sposto, R., Malvar, J., Chen, C. e Freyer, D. R. (2014). Characterization of transfusion-derived iron deposition in
Capítulo 8. Toxicidade e Tratamento de Sintomas 285
Powered by FlippingBook